Jennifer Klem, PhD

Articles

G-CSF Underused in Older Patients Receiving Immunochemotherapy for DLBCL

November 15, 2016

Older patients with diffuse large B-cell lymphoma (DLBCL) often have an increased risk of treatment-related morbidity and mortality, but the use of preventive interventions, such as granulocyte colony-stimulating factor (G-CSF) may help.